Sleep DeprivationHeavyNapNCT06789237
Daytime Napping and Weighted Blankets
A study testing weighted blanket and non-weighted blanket in people with Sleep Deprivation, run by University of Thessaly at 1 site in Greece.
Trial summary
Daytime napping enhances energy restoration, cognitive function, and memory as well as reducing fatigue and improving overall performance. Weighted blankets have been used for improving sleep quality and as a rehabilitation tool for children with neurodevelopmental disorders. Read more about this study
- Who is it for?
- Ages 18 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Sleep Deprivation
- What is being tested?
- weighted blanket and non-weighted blanket
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 20 participants
- Where
- 1 siteGreece
- Study dates
- 7 Feb 2024to 15 Nov 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Capacity to consent
Who cannot join
- history of mental illness
- history of epilepsy
- any acute or chronic condition that would limit the ability of the patient to participate in the study
Trial locations and contacts
1 site in 1 country.
Greece1 site
School of Physical Education, Sports and Dietetics, TEFAA
Trikala, Thessaly, GR42100
About this study
Official title: The Effect of Various Types of Weighted Blanket on Daytime Napping: a Randomized Cross-over Clinical Trial
Daytime napping enhances energy restoration, cognitive function, and memory as well as reducing fatigue and improving overall performance. Weighted blankets have been used for improving sleep quality and as a rehabilitation tool for children with neurodevelopmental disorders. It is not known, however, whether weighted blankets can improve short-duration naps like day-time napping and what is the optimal weight of those blankets for achieving the best results. The purpose of the present study is to investigate for the first time the effect of 4 different weighted blankets on sleep parameters on daytime napping.
Read the detailed description
Study Design Subjects will be randomly assigned into 4 conditions each one week apart: 1) The Control condition (CON), where subjects will lay down and be covered with a cotton blanket identical in appearance and material to the weighted blanket but without any extra weight, 2) The 7 kg condition blanket, where subjects will lay down and be covered with a blanket weighing 7 kg; 3) The 9 kg condition blanket, where subjects will lay down and be covered with a blanket weighing 9 kg; 4) The 14 kg condition blanket, where subjects will lay down and be covered with a blanket weighing 14 kg. All measurements will be conducted at the same sleep lab, at the same time of the day, under controlled conditions, with a constant temperature of 22°C, and dimmed lighting (5 lux), while any possible external sound will be masked using white noise sound at 432 Hz and 55 decibels. The study is approved by the Human Research and Ethics Committee of the University of Thessaly (2329/07/02/2024). All Subjects will give their written informed consent prior to study participation.
Procedure All measurements will be performed in the Lifestyle Medicine Laboratory, at the Department of Physical Education and Sport Science of Trikala, in Thessaly, Greece.
Before the initiation of the study, subjects will complete a series of questionnaires and measurements related to overall health. Subjects will be connected to a portable EEG/EOG system (HST-mit-tablet, Somomedics AG, Randersacker, Germany) for staging sleep architecture. Before and after each condition, subjects will complete a relaxation sensation questionnaire (RSQ) for assessing the state of relaxation and perform 3 maximum handgrip attempts using the dominant hand for assessing the level of muscle strength. Measurements of vital signs such as heart rate and blood pressure will also be recorded with an automatic blood pressure monitor [OMRON Bronze Upper Arm Blood Pressure Monitor]. All the assessments will be conducted on a supine position prior to study initiation. The participants will be free to either sleep or stay awake during the whole intervention period. Furthermore, to ensure result validity and avoid familiarization effects, a random 25% sample of participants will be selected for an additional measurement to determine whether the findings will be influenced by familiarity with the laboratory environment.
Measuring Instruments Body Composition Body composition will be assessed using anthropometric measurements including BMI, and bioimpedance (Tanita DC-360 S, Serinth) under standard methodology.19
Questionnaires The following questionnaires will be administered using the interview method by experienced researchers. The Pittsburgh Sleep Quality Index (PSQI) will be used to assess sleep quality and the existence of any sleep abnormalities. The Short Form survey 36-item 36 quality of life questionnaire (SF-36) will be used to assess the quality of life. The Beck Depression Inventory (BDI) questionnaire will be used to assess depressive symptoms and signs. The Perceived Stress Scale (PSS) will be used to assess the level of stress. Finally, the Relaxation State Questionnaire (RSQ) will be used to assess state of relaxation.
Brain Activity / Sleep Architecture A portable sleep monitoring system will be used to assess sleep quality and quantity (Home Sleep Test, Somnomedics, GmbH, Germany). The system records EEG, EOG, and EMG signals overnight. EEG data will analyzed in 30-second epochs using SomnoMed-ics PSG analysis software (Domino panel ver. 3.0.0.8) with manual editing. Analysis of the sleep study will be reported as followed: Total Sleep Time (total amount of sleep time scored during the total recording time); Sleep Efficiency (Total sleep time/Time in bed); Sustained Sleep Efficiency (Total sleep time/(Time in bed - Sleep laten-cy stage 2); Sleep Latency (the period of time it takes for a person to fall asleep after they have gone to bed and tried to initiate sleep); Sleep Latency N1 (the period of time between wakefulness and when sleep begins); Sleep Latency N2 (the period of time between time in bed and sleep onset stage 2); REM Latency (the amount of time elapsed between the onset of sleep to the first REM stage); Wakes (the number of times an individual wakes up during the sleep period or transitions to full wakefulness after sleep onset).
Handgrip strength assessment The handgrip test will be used for the assessment of maximum isometric strength of the dominant hand and arm muscles (Marsden MG-4800 Hand Dynamometer) and used as a measurement of muscle tone alertness. Reduction of muscle strength after the intervention, will be assessed as reduction of muscle tone.
Statistical Analysis The statistical analysis will be performed using IBM SPSS Statistics version 29 (SPSS Inc., Chicago, U.S.A.) An independent samples T-test will be used to examine differences in baseline characteristics and questionnaires between male and female subjects. A General Linear Model (GLM) Repeated Measures ANOVA will be used to assess changes in all parameters among the 4 different conditions. Additionally, a General Linear Model (GLM) Repeated Measures ANOVA will be used to assess changes in all sleep parameters among the 4 different conditions between good and poor sleepers. A Regression Linear Model will be applied to evaluate the relationship between EEG parameters and the weight of the blankets used. Statistical significance will be set at p≤0.05. Data are presented as mean ± standard deviation (SD), unless otherwise specified. A Bonferroni post-hoc test will be performed to assess individual differences. To assess normality, the Shapiro-Wilk test will be used alongside graphical representations, including the Normal Q-Q plot, Detrended Normal Q-Q plot, and Box Plot. The significance level will be set at 5%. Beyond significance testing (p-value), the effect size will be also considered to evaluate the magnitude of the effect.
Power Analysis Sample size calculations have been conducted using G*Power 3.1. The post-hoc "GLM": Repeated measures, within factors" method has been used to calculate the power analysis. The resulting minimum required sample size to achieve 85% power will be 14 participants for 2-sided group-1 and group-2 errors 5% [(Effect size 0.60, Critical F 4.10, Ndf 2, Ddf 10, Power (1-β err pob) = 0.86 (86% power)].
- Conditions
- Sleep Deprivation
- Being tested
- weighted blanket, non-weighted blanket
- Keywords
- daytime nap, power naps
- Medical subject headings
- Sleep Deprivation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
weighted blanketOther
Participants will be covered with a weighted blanket for 30 minutes
non-weighted blanketOther
Participants will be covered with a sham non-weighted blanket for 30 minute
| Study group | Role | What they receive |
|---|---|---|
| Control | Sham comparator | For the Control condition (CON), subjects will lie down and be covered with a cotton blanket identical in appearance and material to the weighted blanket but without any extra weight, Receives: Other: non-weighted blanket |
| 7 Kg blanket | Experimental | For the 7 kg condition blanket, subjects will lie down and be covered with a blanket weighing 7 kg Receives: Other: weighted blanket |
| 9 Kg blanket | Experimental | For the 9 kg condition blanket, subjects will lie down and be covered with a blanket weighing 9 kg Receives: Other: weighted blanket |
| 14 Kg blanket | Experimental | For the 14 kg condition blanket, subjects will lie down and be covered with a blanket weighing 14 kg Receives: Other: weighted blanket |
What is being measured
The primary outcome is the main question the study is designed to answer.
Total Sleep Time
Total Sleep Time is the total amount of sleep time scored during the total recording time
Measured: At the end of the 30 minutes intervention
Sleep Efficiency
Sleep Efficiency is the ration of Total sleep time/Time in bed
Measured: At the end of the 35 minutes intervention
Secondary outcomes (1)
Relaxation Score
The Relaxation score will be calculated by the Relaxation State Questionnaire assessing the state of relaxation before and after the intervention. The RSQ score ranges from 10 to 50 with a higher score implying a better outcome (the larger the number, the more relaxed is the person).
Measured: At baseline and after the 30 minutes intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jan 2025
- Study start7 Feb 2024
- Primary completion15 Aug 2024
- Study completion15 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Sleep DeprivationStudies of the same condition, open and under way.
- More trials run by University of ThessalyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Thessaly
- Sponsor type
- University, hospital or other
- Collaborators
- University of Nicosia
- Responsible party
- Principal investigator, Giorgos K. Sakkas, University of Thessaly
- Investigators
- Christina Karatzaferi, PhD, Study chair, University of Thessaly
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06789237
- Sponsor's protocol ID
- 2329/07/02/2024
- Acronym
- HeavyNap
- Status last verified
- Jan 2025
- First submitted
- 17 Jan 2025
- Last updated
- 28 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Raw data and study IRB protocol
Publications
Mullen B, Champagne T, Krishnamurty S, Dickson D, Gao RX. Exploring the safety and therapeutic effects of deep pressure stimulation using a weighted blanket. Occup Ther Ment Health. 2008;24(1):65-89.
Dutheil F, Danini B, Bagheri R, Fantini ML, Pereira B, Moustafa F, Trousselard M, Navel V. Effects of a Short Daytime Nap on the Cognitive Performance: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021 Sep 28;18(19):10212. doi: 10.3390/ijerph181910212.
PubMed 34639511
Study at a glance
From the registry record, last updated by the sponsor on 28 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Various Types of Weighted Blanket on Daytime Napping: a Randomized Cross-over Clinical Trial
- ClinicalTrials.gov ID
- NCT06789237
- Acronym / sponsor ID
- HeavyNap / 2329/07/02/2024
- Conditions
- Sleep Deprivation
- Keywords
- daytime nap, power naps
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- University of ThessalyUniversity, hospital or other
- Collaborators
- University of Nicosia
- Study start
- 7 Feb 2024 (actual)
- Primary completion
- 15 Aug 2024 (actual)
- Study completion
- 15 Nov 2024 (actual)
- First posted
- 23 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Daytime napping enhances energy restoration, cognitive function, and memory as well as reducing fatigue and improving overall performance. Weighted blankets have been used for improving sleep quality and as a rehabilitation tool for children with neurodevelopmental disorders. It is not known, however, whether weighted blankets can improve short-duration naps like day-time napping and what is the optimal weight of those blankets for achieving the best results. The purpose of the present study is to investigate for the first time the effect of 4 different weighted blankets on sleep parameters on daytime napping.
Detailed description
Study Design Subjects will be randomly assigned into 4 conditions each one week apart: 1) The Control condition (CON), where subjects will lay down and be covered with a cotton blanket identical in appearance and material to the weighted blanket but without any extra weight, 2) The 7 kg condition blanket, where subjects will lay down and be covered with a blanket weighing 7 kg; 3) The 9 kg condition blanket, where subjects will lay down and be covered with a blanket weighing 9 kg; 4) The 14 kg condition blanket, where subjects will lay down and be covered with a blanket weighing 14 kg. All measurements will be conducted at the same sleep lab, at the same time of the day, under controlled conditions, with a constant temperature of 22°C, and dimmed lighting (5 lux), while any possible external sound will be masked using white noise sound at 432 Hz and 55 decibels. The study is approved by the Human Research and Ethics Committee of the University of Thessaly (2329/07/02/2024). All Subjects will give their written informed consent prior to study participation.
Procedure All measurements will be performed in the Lifestyle Medicine Laboratory, at the Department of Physical Education and Sport Science of Trikala, in Thessaly, Greece.
Before the initiation of the study, subjects will complete a series of questionnaires and measurements related to overall health. Subjects will be connected to a portable EEG/EOG system (HST-mit-tablet, Somomedics AG, Randersacker, Germany) for staging sleep architecture. Before and after each condition, subjects will complete a relaxation sensation questionnaire (RSQ) for assessing the state of relaxation and perform 3 maximum handgrip attempts using the dominant hand for assessing the level of muscle strength. Measurements of vital signs such as heart rate and blood pressure will also be recorded with an automatic blood pressure monitor [OMRON Bronze Upper Arm Blood Pressure Monitor]. All the assessments will be conducted on a supine position prior to study initiation. The participants will be free to either sleep or stay awake during the whole intervention period. Furthermore, to ensure result validity and avoid familiarization effects, a random 25% sample of participants will be selected for an additional measurement to determine whether the findings will be influenced by familiarity with the laboratory environment.
Measuring Instruments Body Composition Body composition will be assessed using anthropometric measurements including BMI, and bioimpedance (Tanita DC-360 S, Serinth) under standard methodology.19
Questionnaires The following questionnaires will be administered using the interview method by experienced researchers. The Pittsburgh Sleep Quality Index (PSQI) will be used to assess sleep quality and the existence of any sleep abnormalities. The Short Form survey 36-item 36 quality of life questionnaire (SF-36) will be used to assess the quality of life. The Beck Depression Inventory (BDI) questionnaire will be used to assess depressive symptoms and signs. The Perceived Stress Scale (PSS) will be used to assess the level of stress. Finally, the Relaxation State Questionnaire (RSQ) will be used to assess state of relaxation.
Brain Activity / Sleep Architecture A portable sleep monitoring system will be used to assess sleep quality and quantity (Home Sleep Test, Somnomedics, GmbH, Germany). The system records EEG, EOG, and EMG signals overnight. EEG data will analyzed in 30-second epochs using SomnoMed-ics PSG analysis software (Domino panel ver. 3.0.0.8) with manual editing. Analysis of the sleep study will be reported as followed: Total Sleep Time (total amount of sleep time scored during the total recording time); Sleep Efficiency (Total sleep time/Time in bed); Sustained Sleep Efficiency (Total sleep time/(Time in bed - Sleep laten-cy stage 2); Sleep Latency (the period of time it takes for a person to fall asleep after they have gone to bed and tried to initiate sleep); Sleep Latency N1 (the period of time between wakefulness and when sleep begins); Sleep Latency N2 (the period of time between time in bed and sleep onset stage 2); REM Latency (the amount of time elapsed between the onset of sleep to the first REM stage); Wakes (the number of times an individual wakes up during the sleep period or transitions to full wakefulness after sleep onset).
Handgrip strength assessment The handgrip test will be used for the assessment of maximum isometric strength of the dominant hand and arm muscles (Marsden MG-4800 Hand Dynamometer) and used as a measurement of muscle tone alertness. Reduction of muscle strength after the intervention, will be assessed as reduction of muscle tone.
Statistical Analysis The statistical analysis will be performed using IBM SPSS Statistics version 29 (SPSS Inc., Chicago, U.S.A.) An independent samples T-test will be used to examine differences in baseline characteristics and questionnaires between male and female subjects. A General Linear Model (GLM) Repeated Measures ANOVA will be used to assess changes in all parameters among the 4 different conditions. Additionally, a General Linear Model (GLM) Repeated Measures ANOVA will be used to assess changes in all sleep parameters among the 4 different conditions between good and poor sleepers. A Regression Linear Model will be applied to evaluate the relationship between EEG parameters and the weight of the blankets used. Statistical significance will be set at p≤0.05. Data are presented as mean ± standard deviation (SD), unless otherwise specified. A Bonferroni post-hoc test will be performed to assess individual differences. To assess normality, the Shapiro-Wilk test will be used alongside graphical representations, including the Normal Q-Q plot, Detrended Normal Q-Q plot, and Box Plot. The significance level will be set at 5%. Beyond significance testing (p-value), the effect size will be also considered to evaluate the magnitude of the effect.
Power Analysis Sample size calculations have been conducted using G*Power 3.1. The post-hoc "GLM": Repeated measures, within factors" method has been used to calculate the power analysis. The resulting minimum required sample size to achieve 85% power will be 14 participants for 2-sided group-1 and group-2 errors 5% [(Effect size 0.60, Critical F 4.10, Ndf 2, Ddf 10, Power (1-β err pob) = 0.86 (86% power)].
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Control | Sham comparator | Other: non-weighted blanketFor the Control condition (CON), subjects will lie down and be covered with a cotton blanket identical in appearance and material to the weighted blanket but without any extra weight, |
| 7 Kg blanket | Experimental | Other: weighted blanketFor the 7 kg condition blanket, subjects will lie down and be covered with a blanket weighing 7 kg |
| 9 Kg blanket | Experimental | Other: weighted blanketFor the 9 kg condition blanket, subjects will lie down and be covered with a blanket weighing 9 kg |
| 14 Kg blanket | Experimental | Other: weighted blanketFor the 14 kg condition blanket, subjects will lie down and be covered with a blanket weighing 14 kg |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Capacity to consent
Key exclusion criteria (3 listed)
- history of mental illness
- history of epilepsy
- any acute or chronic condition that would limit the ability of the patient to participate in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| weighted blanketParticipants will be covered with a weighted blanket for 30 minutes | Other | 14 Kg blanket, 7 Kg blanket, 9 Kg blanket |
| non-weighted blanketParticipants will be covered with a sham non-weighted blanket for 30 minute | Other | Control |
Primary outcome
Total Sleep Time
Time frame: At the end of the 30 minutes intervention
Total Sleep Time is the total amount of sleep time scored during the total recording time
Sleep Efficiency
Time frame: At the end of the 35 minutes intervention
Sleep Efficiency is the ration of Total sleep time/Time in bed
1 secondary outcome
Relaxation Score
Time frame: At baseline and after the 30 minutes intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jan 2025.
- BackgroundMullen B, Champagne T, Krishnamurty S, Dickson D, Gao RX. Exploring the safety and therapeutic effects of deep pressure stimulation using a weighted blanket. Occup Ther Ment Health. 2008;24(1):65-89.
- Background: PubMed 34639511Dutheil F, Danini B, Bagheri R, Fantini ML, Pereira B, Moustafa F, Trousselard M, Navel V. Effects of a Short Daytime Nap on the Cognitive Performance: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021 Sep 28;18(19):10212. doi: 10.3390/ijerph181910212.
- Individual participant dataSharing planned: Yes. Raw data and study IRB protocol
Related trials for Sleep Deprivation
Not yet recruiting
Study on the Mechanism of Central Obesity Induced by Sleep Restriction and the Therapeutic Effect of n-3 Polyunsaturated Fatty Acid: a Randomized, Double-blind, Placebo-controlled Trial (COSPA Study)
Sleep Deprivation
Recruiting
Sleep and Circadian Rhythm Intervention in ICU
ICU Hospitalization, Circadian Rhythm
Recruiting
Effect of Sleep Extension in Prevention to Sleep Deprivation
Healthy
Not yet recruiting
Evolution of Sleep in Intensive Care Unit Patients
ICU, Sleep Deprivation
Active, not recruiting
The Effect of Sleep Deprivation and Recovery Sleep on Emotional Memory and Affective Reactivity
Sleep Deprivation, Sleep
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christina Karatzaferi, PhD study chair
University of Thessaly
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing weighted blanket and non-weighted blanket in people with Sleep Deprivation, run by University of Thessaly at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Total Sleep Time (time frame: At the end of the 30 minutes intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06789237, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2025.